Article

Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells.

Department of Hematology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Nature Immunology (Impact Factor: 26.2). 12/2008; 10(1):66-74. DOI: 10.1038/ni.1668
Source: PubMed

ABSTRACT The human body contains over 500 individual lymph nodes, yet the biology of their formation is poorly understood. Here we identify human lymphoid tissue-inducer cells (LTi cells) as lineage-negative RORC+ CD127+ cells with the functional ability to interact with mesenchymal cells through lymphotoxin and tumor necrosis factor. Human LTi cells were committed natural killer (NK) cell precursors that produced interleukin 17 (IL-17) and IL-22. In vitro, LTi cells gave rise to RORC+ CD127+ NK cells that retained the ability to produce IL-17 and IL-22. Postnatally, similar populations of LTi cell-like cells and RORC+ CD127+ NK cells were present in tonsils, and both secreted IL-17 and IL-22 but no interferon-gamma. Our data indicate that lymph node organogenesis is controlled by an NK cell precursor population with adaptive immune features and demonstrate a previously unappreciated link between the innate and adaptive immune systems.

1 Bookmark
 · 
192 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: RORγt(+) innate lymphoid cells (ILCs), or ILC3, play a fundamental role in the development of lymphoid tissues, as well as in homeostasis and defence of mucosal tissues. These cells produce IL-22, IL-17A and LTα1β2, key cytokines for the activation of epithelial defences and the recruitment of polymorphonuclear phagocytes. In the absence of ILC3, the early defence to infection and resistance to injury are compromised. Given the importance of ILC3 in mucosal immunity, significant efforts are made to discover their multiple functions and decipher their mode of action and regulation.
    FEBS letters 03/2014; · 3.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. Interleukin (IL)-22 is emerging as a key cytokine for gut epithelial homeostasis and mucosal repair. Gut disruption is a hallmark of HIV infection. Here we investigated IL-22 production and gut mucosal integrity in HIV-1-infected individuals receiving long-term antiretroviral therapy (ART).Methods. Biopsies from 37 individuals performing colonoscopy primarily for cancer screening, 17 HIV-1-infected and 20 healthy age-matched controls, were assessed.Results. We found significant depletion of sigmoid IL-22-producing CD4 T-cells (Th22) even after prolonged ART, contrasting with the apparently normal compartments of regulatory and IL-17-producing, as well as total mucosal CD4 T-cells. Despite the preferential Th22 depletion, IL-22-production by innate lymphoid cells (ILC) was similar to that observed in seronegatives, and transcription of molecules relevant for IL-22 production was preserved (AHR, IL23, IL23R, IL1B, IL6, and TGFB1). Remarkably, transcripts of IL-22 target genes (REG3G, DEFB4A, S100A9, MUC1, MUC13) were unaltered, suggesting an adequate production of antimicrobial peptides and mucins. In agreement, enteric epithelial architecture was fully preserved.Conclusion. Despite the reduced Th22 subset, innate IL-22-mediated mechanisms, essential for sigmoid mucosa integrity, were fully operational in long-term treated HIV-1-infected individuals. Our data highlight IL-22-production by ILC as an important target for therapies aimed at facilitating human mucosal reconstitution.
    The Journal of Infectious Diseases 03/2014; · 5.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Innate lymphoid cells (ILC) are increasingly appreciated as important regulators of tissue homeostasis and inflammation. However, their role in human skin remains obscure. We found that healthy peripheral blood CD117(+) ILC3, lacking the natural cytotoxicity receptor (NCR) NKp44 (NCR(-) ILC3), CD117(-)NCR(-)CRTH2(-)CD161(+) ILC1 and CRTH2(+) ILC2 express the skin-homing receptor cutaneous lymphocyte antigen (CLA). NCR(+) ILC3 were scarce in peripheral blood. Consistently, we identified in normal skin ILC2 and NCR(-) ILC3, a small proportion of CD161(+) ILC1, and hardly any NCR(+) ILC3 whereas NCR(+) ILC3 were present in cultured dermal explants. The skin ILC2 and NCR(+) ILC3 subsets produced IL-13 and IL-22, respectively, upon cytokine stimulation. Remarkably, dermal NCR(-) ILC3 converted to NCR(+) ILC3 upon culture in IL-1β plus IL-23, cytokines known to be involved in psoriatic inflammation. In line with this observation, significantly increased proportions of NCR(+) ILC3 were present in lesional skin and peripheral blood of psoriasis patients as compared to skin and blood of healthy individuals, respectively, whereas the proportions of ILC2 and CD161(+) ILC1 remained unchanged. NCR(+) ILC3 from skin and blood of psoriasis patients produced IL-22, which is regarded as a key driver of epidermal thickening, suggesting that NCR(+) ILC3 may participate in psoriasis pathology.Journal of Investigative Dermatology accepted article preview online, 21 March 2014; doi:10.1038/jid.2014.146.
    Journal of Investigative Dermatology 03/2014; · 6.19 Impact Factor